Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 7/20 | 0.57 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 6/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.47 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.41 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.41 |
| ▸ | NCK1 | P16333 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | NQO2 | P16083 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20457628 | 0.93 | CYP1A2 (0.50) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL24065238 | 0.89 | CYP2A6 (0.50) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL607927 | 0.89 | CYP1A2 (0.71) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL20457660 | 0.88 | CYP2A6 (0.48) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL597341 | 0.87 | CYP1A2 (0.67) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL23555855 | 0.84 | CYP1A2 (0.72) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL23624460 | 0.83 | ALDH1A1 (0.50) | CYP2A6LMNAKDM4EALDH1A1GAA | |
| SCHEMBL19287326 | 0.82 | CYP1A2 (0.68) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL598308 | 0.82 | CYP1A2 (0.60) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 | |
| SCHEMBL9187014 | 0.82 | CYP1A2 (0.68) | CYP1A2CYP2A6LMNAKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11770974-B2 | P active materials for organic photoelectric conversion layers in organic photodiodes | SONY CORPORATION (JP) | 2023-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11770974-B2 | P active materials for organic photoelectric conversion layers in organic photodiodes | JUP, L1CAM, EPCAM | CYP1A2 1899/4885CYP2A6 3601/4885LMNA 720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.